Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer (Q36614598)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 2006
edit
Language Label Description Also known as
English
Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer
scientific article published on May 2006

    Statements

    Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer (English)
    U Graeven
    B Kremer
    Th Südhoff
    B Killing
    D Weber
    J Tillner
    W Schmiegel
    1 May 2006
    1293-1299

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit